Gym News Today — September 28, 2026

As we continue to navigate the complexities of health and wellness, it's clear that there's always more to learn about our bodies and the ways we can support them. Today, we're highlighting a mix of stories that showcase both the promise and the challenges of medical research. On one hand, we're seeing exciting developments in the field of genetic treatment, with a CRISPR therapy that successfully lowered "bad" cholesterol levels in patients for a full year. Meanwhile, research on common blood thinners has revealed a significant reduction in risk for atrial fibrillation patients.

But alongside these breakthroughs, we're also being reminded of the importance of caution and further study. For example, a popular joint supplement has been linked to faster progression of Alzheimer's disease, highlighting the need for careful consideration when adding new supplements to our regimens. And for those living with rheumatoid arthritis, new insights into the persistence of pain even after inflammation is under control are shedding light on the complexities of this condition. Finally, an unexpected source - house cats - may hold the key to unlocking better cancer treatments for humans, demonstrating the often-surprising ways that animal research can inform human health.

Today's signal:
• Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression (sciencedaily.com)
• Atrial fibrillation patients saw 69% lower risk with common blood thinners (sciencedaily.com)
• One CRISPR treatment cut “bad” cholesterol in half for a full year (sciencedaily.com)
• Why rheumatoid arthritis pain may persist even when inflammation is under control (sciencedaily.com)
• Scientists say house cats could help unlock better cancer treatments for humans (sciencedaily.com)